Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00407732 · ClinicalTrials.gov registry record · NA

Overcoming Psychiatric Barriers to the Treatment of Hepatitis C

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT00407732 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 101 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00407732, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate candidates for interferon therapy.

Interventions

  • BEHAVIORAL psychosocial intervention

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2007-01
Est. Completion 2011-10
Phase NA

What the Registry Record Tells You About NCT00407732

The ClinicalTrials.gov registry entry for NCT00407732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which psychosocial intervention is the first listed.

NCT00407732 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00407732 about?

NCT00407732 is a clinical study titled "Overcoming Psychiatric Barriers to the Treatment of Hepatitis C". The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate candidates for interferon therapy.

What is the current status of trial NCT00407732?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2007-01. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00407732?

The interventions under investigation include: psychosocial intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00407732?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.